Evidence map›Paper›PMID 37781402›Full record

ArticleFrontiers in immunology2023

Curation and expansion of the Human Phenotype Ontology for systemic autoinflammatory diseases improves phenotype-driven disease-matching.

Willem Maassen, Geertje Legger, Ovgu Kul Cinar, Paul van Daele, Marco Gattorno, Brigitte Bader-Meunier, Carine Wouters, Tracy Briggs, Lennart Johansson, Joeri van der Velde and 11 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 6 countries.

Willem MaassenGenomics Coordination Centre, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Geertje LeggerDepartment of Rheumatology and Clinical Immunology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Ovgu Kul CinarDepartment of Paediatric Rheumatology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Paul van DaeleDepartment of Internal Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.
Marco GattornoUOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannini Gaslini, Genoa, Italy.
Brigitte Bader-MeunierDepartment of Paediatric Immunology-Hematology and Rheumatology, Necker University Hospital - APHP, Paris, France.
Carine WoutersDepartment of Pediatric Rheumatology, University Hospital Leuven, Leuven, Belgium.
Tracy BriggsDivision of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Lennart JohanssonGenomics Coordination Centre, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Joeri van der VeldeGenomics Coordination Centre, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Morris SwertzGenomics Coordination Centre, Department of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Ebun OmoyinmiDepartment of Paediatric Rheumatology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Esther HoppenreijsDepartment of Pediatric Rheumatology, Pediatrics, Radboud University Medical Center, Nijmegen, Netherlands.
Alexandre BelotNational Referee Centre for Rheumatic and AutoImmune and Systemic Diseases in Children (RAISE), Pediatric Nephrology, Rheumatology, Dermatology Unit, INSERM, Hospital of Mother and Child, Hospices Civils of Lyon, Lyon, France.
Despina EleftheriouDepartment of Paediatric Rheumatology, Great Ormond Street Hospital for Children National Health Service Trust, London, United Kingdom.
Roberta CaorsiUOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannini Gaslini, Genoa, Italy.
Florence AeschlimannDepartment of Paediatric Immunology-Hematology and Rheumatology, Necker University Hospital - APHP, Paris, France.
Guilaine BoursierLaboratory of Rare and Autoinflammatory Genetic Diseases and Reference Centre for Autoinflammatory Diseases and Amyloidosis (CEREMAIA), Department of Medical Genetics, Rare Diseases and Personalized Medicine, CHU Montpellier, University of Montpellier, Montpellier, France.
Paul BroganInflammation and Rheumatology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
Matthias HaimelBoehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Marielle van GijnDepartment of Genetics, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
University of Groningen · NLIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity College London · GBUniversity Medical Center Groningen · NLBoehringer Ingelheim (Austria) · ATErasmus University Rotterdam · NLGreat Ormond Street Hospital · GBHôpital Necker-Enfants Malades · FRInstitut des Maladies Génétiques Imagine · FRNational Health Service · GBRadboud University Medical Center · NLUniversité Claude Bernard Lyon 1 · FRUniversité de Montpellier · FRUniversity of Manchester · GB

Funding

Versus Arthritis 21791
6 · The paper itself

Abstract

Introduction: Accurate and standardized phenotypic descriptions are essential in diagnosing rare diseases and discovering new diseases, and the Human Phenotype Ontology (HPO) system was developed to provide a rich collection of hierarchical phenotypic descriptions. However, although the HPO terms for inborn errors of immunity have been improved and curated, it has not been investigated whether this curation improves the diagnosis of systemic autoinflammatory disease (SAID) patients. Here, we aimed to study if improved HPO annotation for SAIDs enhanced SAID identification and to demonstrate the potential of phenotype-driven genome diagnostics using curated HPO terms for SAIDs. Methods: We collected HPO terms from 98 genetically confirmed SAID patients across eight different European SAID expertise centers and used the LIRICAL (Likelihood Ratio Interpretation of Clinical Abnormalities) computational algorithm to estimate the effect of HPO curation on the prioritization of the correct SAID for each patient. Results: Our results show that the percentage of correct diagnoses increased from 66% to 86% and that the number of diagnoses with the highest ranking increased from 38 to 45. In a further pilot study, curation also improved HPO-based whole-exome sequencing (WES) analysis, diagnosing 10/12 patients before and 12/12 after curation. In addition, the average number of candidate diseases that needed to be interpreted decreased from 35 to 2. Discussion: This study demonstrates that curation of HPO terms can increase identification of the correct diagnosis, emphasizing the high potential of HPO-based genome diagnostics for SAIDs.

Indexed as

Hereditary Autoinflammatory DiseasesSimian Acquired Immunodeficiency SyndromeAnimalsDatabases, GeneticHumansPhenotypePilot Projectsgenome diagnosticsHuman Phenotype Ontology (HPO)LIRICALsystemic autoinflammatory disorders (SAIDs)variant interpretationwhole exome sequencing (WES)

Identifiers

PMID37781402
PMCPMC10536149
OpenAlexW4386686842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.